Company Info

Ticker

ALKS (NasdaqGS)

Revenue

$667.7

Visit Website

Alkermes

CDMO

Tagline

Patient Inspired

Overview

Alkermes Contract Pharma Services is a provider of solid oral dosage product development, scale-up and manufacturing services as well as sterile fill finish capabilities to the global pharmaceutical market. With over 40 years of experience, the company offers a range of capabilities to support customer requirements including tech transfers, proven and validated technology and process improvement solutions, and an exceptional compliance track record in both the U.S. and EU.

Company Services

Services/CapabilitiesCDMO

+ Development Services

Analytical Development & Validation
Bioanalytical Services
Preformulation/Formulation
Process Development & Validation
Raw Material Testing
Scale Up/Tech Transfer
Stability Testing

+ Drug Product Manufacturing

Lyophilized Products Manufacturing
Sterile Bags Manufacturing

+ Drug Substance Manufacturing

Controlled Substances

+ Packaging

Carton Packaging
Prefilled Syringes/Cartridges/Pen Devices

Contributions

Alkermes Announces the Appointment of Board of Directors

Alkermes Launches Award Program To Support And Advance Central Nervous System Disorders Research

Alkermes Completes Patient Enrollment in Pivotal Weight Study of ALKS 3831 for Schizophrenia

Study Reveals New Medication Options for Opioid Dependency

Patients Switched to Alkermes’ ARISTADA® Showed Significant Improvement in Schizophrenia Symptoms After Inadequate Response or Intolerance to INVEGA SUSTENNA®